0NHS Stock Overview
Provides crop inputs and services. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Nutrien Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$44.30 |
| 52 Week High | CA$60.64 |
| 52 Week Low | CA$43.74 |
| Beta | 0.93 |
| 1 Month Change | -3.60% |
| 3 Month Change | -8.04% |
| 1 Year Change | -21.28% |
| 3 Year Change | -40.85% |
| 5 Year Change | -4.41% |
| Change since IPO | -18.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0NHS | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | -1.4% | 0.7% | 0.8% |
| 1Y | -21.3% | -25.4% | 2.7% |
Return vs Industry: 0NHS exceeded the UK Chemicals industry which returned -25.4% over the past year.
Return vs Market: 0NHS underperformed the UK Market which returned 2.7% over the past year.
Price Volatility
| 0NHS volatility | |
|---|---|
| 0NHS Average Weekly Movement | 3.5% |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0NHS has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0NHS's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 25,900 | Ken Seitz | www.nutrien.com |
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products.
Nutrien Ltd. Fundamentals Summary
| 0NHS fundamental statistics | |
|---|---|
| Market cap | US$21.90b |
| Earnings (TTM) | US$733.00m |
| Revenue (TTM) | US$25.56b |
29.9x
P/E Ratio0.9x
P/S RatioIs 0NHS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0NHS income statement (TTM) | |
|---|---|
| Revenue | US$25.56b |
| Cost of Revenue | US$17.84b |
| Gross Profit | US$7.72b |
| Other Expenses | US$6.98b |
| Earnings | US$733.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.48 |
| Gross Margin | 30.20% |
| Net Profit Margin | 2.87% |
| Debt/Equity Ratio | 53.4% |
How did 0NHS perform over the long term?
See historical performance and comparisonDividends
4.9%
Current Dividend Yield145%
Payout RatioDoes 0NHS pay a reliable dividends?
See 0NHS dividend history and benchmarks| Nutrien dividend dates | |
|---|---|
| Ex Dividend Date | Dec 31 2024 |
| Dividend Pay Date | Jan 17 2025 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 19 days |
Does 0NHS pay a reliable dividends?
See 0NHS dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 17:30 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nutrien Ltd. is covered by 69 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Harriet Li | Accountability Research Corporation |
| Keith Carpenter | ATB Capital Markets |
| Ishan Majumdar | Baptista Research |